期刊文献+

醛固酮与糖尿病及其慢性并发症的关系 被引量:14

Relationship between aldosterone and diabetes mellitus and its chronic complications
在线阅读 下载PDF
导出
摘要 醛固酮合成酶基因(CYP11B2)部分位点的多态性改变除导致血浆醛固酮水平发生改变外,还与血糖变化密切相关。作者除对醛固酮传统的水钠滞留导致容量性血压升高外,还参与或介导了血管紧张素Ⅱ的部分靶器官损伤作用,与糖尿病及其慢性并发症的发生和进展有关作一综述,并对醛固酮受体拮抗剂在糖尿病慢性并发症中的治疗意义进行了分析与讨论。 Several genetic polymorphisms of the aldosterone synthase gene (CYP11B2), which may influence the plasma aldosterone levels, had been reported to influence the blood glucose levels. In addition to the effects of sodium ( and consequently water) resorption and potassium excretion, aldosterone could be involved in the development and progression of diabetes and its chronic complications. This paper also discussed the therapeutic significance of aldosterone receptor antagonists on the occcurance of chronic diabetic complications.
出处 《医学研究生学报》 CAS 2007年第5期548-552,共5页 Journal of Medical Postgraduates
基金 南京医科大学发展基金资助项目(批准号:NY04059)
关键词 醛固酮 醛固酮受体拮抗剂 糖尿病 慢性并发症 Aldosterone Aldosterone receptor antagonist Diabetes Chronic complications
作者简介 王霞娟(1972-),女,江苏江阴人,主治医师,医学硕士,从事内分泌专业。
  • 相关文献

参考文献29

  • 1Lakkis J,Lu WX,Weir MR.RAAS escape:a real clinical entity that may be important in the progression of cardiovascular and renal disease[J].Curr Hypertens Rep,2003,5(5):408-417.
  • 2Sato A,Hayashi K,Naruse M,et al.Effectiveness of aldosterone blockade in patient with diabetic nephropathy[J].Hypertension,2003,41 (1):64-68.
  • 3夏正坤,祁建胜,刘光陵.血管紧张素Ⅱ受体拮抗剂在IgA肾病中的临床应用[J].医学研究生学报,2005,18(5):451-453. 被引量:5
  • 4Struthers AD,MacDonald TM.Review of aldosterone-and angiotensin Ⅱ-induced target organ damage and prevention[J].Cardiovascular Res,2004,61 (4):663-670.
  • 5Ambroisine ML,Milliez P,Nehme J,et al.Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy[J].Diabetes Metab,2004,30(4):311-318.
  • 6Nelson DR,Kamataki T,Waxman DJ,et al.The P450 superfamily:update on new sequences,gene mapping,accession numbers,early trivial names of enzymes,and nomenclature[J].DNA Cell Biol,1993,12(1):1-51.
  • 7Taymans SE,Pack S,Pak E,et al.Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3[J].J Clin Endocrinol Metab,1998,83 (3):1033-1036.
  • 8Castellano M,Glorioso N,Cusi D,et al.Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population:the GENIPER Project[J].J Hypertens,2003,21 (10):1853-1860.
  • 9孙晓健,侯晓菲,刘少荣,刘文波,陶志刚,李建远.醛固酮合成酶基因-344T/C多态性与山东省汉族人原发性高血压相关性[J].中华医学遗传学杂志,2004,21(5):502-504. 被引量:33
  • 10Ranade K,Wu KD,Risch N,et al.Genetic variation in aldosterone synthase predicts plasma glucose levels[J].Proc Natl Acad Sci USA,2001,98(23):13219-13224.

二级参考文献23

  • 1Kupari M,Hautanen A,Lankinen L,et al. Associations between human aldosterone synthase gene(CYP11B2) polymorphisms and left ventricular size,mass,and function. Circulation, 1998,97:569-575.
  • 2Komiya I,Yamada T,Takara M,et al. Lys(173) and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension,2000,35:699-703.
  • 3Pojoga L,Gautier S,Blanc H,et al. Genetic determination of plasma aldosterone level in essential hypertension . Am J Hypertens,1998,11:856-860.
  • 4Davies E,Holloway CD,Ingram MC,et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension, 1999,33:703-707.
  • 5Brand E,Chatelain N,Mulatero P,et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension,1998,32:198-204.
  • 6Tsujita Y, Iwai N,Katsuya T,et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the suite study. Hypertens Res,2001,24:105-109.
  • 7Tamaki S,Iwai N,Tsujita Y,et al. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension,1999,33:266-270.
  • 8Wardle EN. Rationales for treating IgA nephropathies[J]. Ren Fail,2000,22(1):1-16.
  • 9Sandberg K, Ji H. Kidney Angiotensin receptors and their role in renal pathophysiology [J]. Semin Nephrol,2000,20(5):402-416.
  • 10Mackenzie HS, Ziai F, Omer SA et al. Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future[J].J Am Soc Nephrol,1999,10(Suppl):S283-286.

共引文献36

同被引文献164

引证文献14

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部